Clinical Trial Update: Progestagens for the Tertiary Prophylaxis of Preterm Delivery [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update reports the completion of a study evaluating progestagens for tertiary prophylaxis of preterm delivery, focusing on preterm birt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Complications
• Preterm Birth

Drugs mentioned

• Progestagens

Snippet

Sponsor: University of Modena and Reggio Emilia | Conditions: Preterm Delivery, Neonatal Complications | Phase 3 | Status: COMPLETED